Unauthorized

• El modelo de IA Mythos de Anthropic, que la empresa consideró demasiado peligroso para su lanzamiento público, presuntamente ha sido accedido por un tercero no autorizado en una brecha de seguridad significativa. • El incidente ha generado preocupaciones globales sobre la seguridad de la IA y los protocolos de seguridad que rodean a los sistemas de IA avanzados, particularmente aquellos modelos marcados como de alto riesgo por sus desarrolladores. • La brecha subraya las tensiones actuales entre las consideraciones de seguridad de la IA y las vulnerabilidades de ciberseguridad en la gestión de modelos de lenguaje de vanguardia.

• Anthropic is investigating unauthorized access to its Mythos AI tool, a critical cybersecurity system, after reports revealed that an unauthorized group breached the platform via a vendor vulnerability. • The incident raises fresh concerns about security gaps within advanced AI systems and amplifies questions about the trustworthiness of AI tools handling sensitive security functions. • The breach exemplifies broader risks in the interconnected tech ecosystem, where vendor compromises can cascade into exposures of high-value AI infrastructure.

• The FDA issued an urgent safety alert on March 20, 2026, warning of counterfeit versions of semaglutide and tirzepatide circulating through unverified online retailers, with 47 adverse events reported including severe infections and allergic reactions. • Counterfeit products lack sterility assurance and may contain contaminated ingredients or incorrect dosing, posing serious health risks to consumers seeking weight loss or diabetes treatment. • The agency recommends patients obtain GLP-1 medications only through licensed pharmacies with valid prescriptions, emphasizing that legitimate suppliers require medical supervision.